Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine
Conditions:   Patient Satisfaction;   Patient Preference;   Quality of Life;   Acceptability of Health Care Intervention:   Sponsors:   Pontificia Universidad Catolica de Chile;   ViiV Healthcare Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2023 Category: Research Source Type: clinical trials